Multiple signaling pathways coordinately mediate reactive oxygen species dependent cardiomyocyte hypertrophy

Cell Biochemistry and Function

Volumn 26, Issue 3, 2008, Pages 346-351

  Adiga, Indira K ^a   Nair, Renuka R ^a  

^a SREE CHITRA TIRUNAL INSTITUTE FOR MEDICAL SCIENCES AND TECHNOLOGY   (India)

Author keywords

Cardiomyocyte hypertrophy; Oxidative stress; Reactive oxygen species; Signaling pathways

Indexed keywords

CALCINEURIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE C; REACTIVE OXYGEN METABOLITE; XANTHINE OXIDASE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; ENZYME ACTIVATION; ENZYME INHIBITION; HEART; HEART HYPERTROPHY; NEWBORN; NEWBORN PERIOD; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

ANIMALS; ANIMALS, NEWBORN; CELL SIZE; CELLS, CULTURED; HYPERTROPHY; HYPOXANTHINE; MYOCYTES, CARDIAC; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; SUPEROXIDES; XANTHINE OXIDASE;

RATTUS;

EID: 42949157393     PISSN: 02636484     EISSN: 10990844     Source Type: Journal    
DOI: 10.1002/cbf.1449     Document Type: Article

References (34)

1. Pimentel DR, Adachi T, Ido Y, et al. Strain-stimulated hypertrophy in cardiac myocytes is mediated by reactive oxygen species-dependent Ras S-glutathiolation. J Mol Cell Cardiol 2006; 41: 613-622.
2. Chen Q, Tu V, Wu Y, Bahl J. Hydrogen peroxide dose dependent induction of cell death or hypertrophy in cardiomyocytes. Arch Biochem Biophys 2000; 373: 242-248.
3. Tu VC, Bahl JJ, Chen QM. Signals of oxidant-induced cardiomyocyte hypertrophy: key activation of p70 S6 kinase-1 and phosphoinositide 3-kinase. J Pharmacol Exp Ther 2002; 300: 1101-1110.
4. Dhalla AK, Hill MF, Singal PK. Role of oxidative stress in transition of hypertrophy to heart failure. J Am Coll Cardiol 1996; 28: 506-514.
5. Hill MF, Singal PK. Antioxidant and oxidative stress changes during heart failure subsequent to myocardial infarction in rats. Am J Pathol 1996; 148: 291-300.
6. Aikawa R, Nagai T, Tanaka M, et al. Reactive oxygen species in mechanical stress-induced cardiac hypertrophy. Biochem Biophys Res Commun 2001; 289: 901-907.
7. Date MO, Morita T, Yamashita N, et al. The antioxidant N-2-mercaptopropionyl glycine attenuates left ventricular hypertrophy in in vivo murine pressure-overload model. J Am Coll Cardiol 2002; 39: 907-912.
8. Adiga IK, Nair RR. A positive association between cardiomyocyte volume and serum malondialdehyde levels. Int J Cardiol 2007; 115: 246-248.
9. Tsujimoto I, Hikoso S, Yamaguchi O, et al. The antioxidant edaravone attenuates pressure overload-induced left ventricular hypertrophy. Hypertension 2005; 45: 921-926.
10. Cheng TH, Shih NL, Chen CH, et al. Role of mitogen-activated protein kinase pathway in reactive oxygen species-mediated endothelin-1-induced beta-myosin heavy chain gene expression and cardiomyocyte hypertrophy. J Biomed Sci 2005; 12: 123-133.
11. de Jonge HW, Dekkers DH, Houtsmuller AB, Sharma HH, Lamers JM. Differential signaling and hypertrophic responses in cyclically stretched vs endothelin-1 stimulated neonatal rat cardiomyocytes. Cell Biochem Biophys 2007; 47: 21-32.
12. Sanna B, Bueno OF, Dai Y-S, Wilkins BJ, Molkentin JD. Direct and indirect interactions between calcinuerin-NFAT and MEK 1-extracellular signal regulated kinase 1/2 signaling pathways regulate cardiac gene expression and cellular growth. Mol Cell Biol 2005; 25: 865-878.
13. Wilkins BJ, Molkentin JD. Calcium-calcineurin signaling in the regulation of cardiac hypertrophy. Biochem Biophys Res Commun 2004; 322: 1178-1191.
14. Wilkins BJ, Dai YS, Bueno OF, et al. Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy. Circ Res 2004; 94: 110-118.
15. Nair RR, Gupta PN. Isolation and culture of beating cells from human fetal heart. J Tissue Cult Meth 1989; 11: 211-216.
16. Simpson P, McGrath A, Savion S. Myocyte hypertrophy in neonatal rat heart cultures and its regulation by serum and by catecholamines. Circ Res 1982; 51: 787-801.
17. Winterbourne DJ. Chemical assays for protein. In Methods in Molecular Biology, Vol. 19. Higgins GJ (ed.). Humana Press, Inc.: New Jersey, 1993; 197-202.
18. Wippich N, Peschke D, Peschke E, Holtz J, Bromme HJ. Comparison between xanthine oxidases from buttermilk and microorganisms regarding their ability to generate reactive oxygen species. Int J Mol Med 2001; 7: 211-216.
19. Johnston RB. Secretionofsuperoxideanion. In Methods for Studying Mononuclear Phagocytes, R van Furth (ed.). Martinus Nighoff: The Hague, 1981; 489-497.
20. 2. Cardiovasc Res 2003; 58: 575-581.
21. Richard MJ, Guiraud P. Methodological and practical aspects for in vitro studies of oxidative stress on cell culture models. In Analysis of Free Radicals in Biological Systems, Favier AE (ed.). Springer Verlag: Switzerland, 1995; 261-275.
22. Barros LF, Hermosilla T, Castro J. Necrotic volume increase and the early physiology of necrosis. Comp Biochem Physiol A Mol Integr Physiol 2001; 130: 401-409.
23. Nakano H. A revival of old players. EMBO Rep 2005; 6: 126-127.
24. Molkentin JD, Dorn GW. 2nd, Cytoplasmic signaling pathways that regulate cardiac hypertrophy. Annu Rev Physiol 2001; 63: 391-426.
25. De Windt LJ, Lim HW, Taigen T, et al. Calcineurin mediated hypertrophy protects cardiomyocytes from apoptosis in vitro and in vivo: an apoptosis independent model of dialated heart failure. Circ Res 2000; 86: 255-263.
26. Vega RB, Yang J, Rothermel BA, Bassel DR, Williams RS. Multiple domains of MCIP1 contribute to inhibition of calcineurin activity. J Biol Chem 2002; 277: 30401-30407.
27. Bogoyevitch MA, Parker SJ, Sugden PH. Characterization of protein kinase C isotype expression in adult rat heart. Protein kinase C-epsilon is a major isotype present, and it is activated by phorbol esters, epinephrine, and endothelin. Circ Res 1993; 72: 757-767.
28. Chien KR, Knowlton KU, Zhu H, Chien S. Regulation of cardiac gene expression during myocardial growth and hypertrophy: molecular studies of an adaptive physiologic response. FASEB J 1991; 15: 3037-3046.
29. Zou Y, Atsuki Y, Zhu W, et al. Isoproterenol activates extracellular signal-regulated protein kinases in cardiomyocytes through calcineurin. Circulation 2001; 104: 102-108.
30. Zou Y, Hiroi Y, Uozumi H, et al. Calcineurin plays a ciritical role in the development of pressure overload-induced cardiac hypertrophy. Circulation 2001; 104: 97-101.
31. Molkentin JD, Lu JR, Antos CL, et al. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 1998; 93: 215-228.
32. Zhang Y, Bloem LJ, Yu L, et al. Protein kinase C beta II activation induces angiotensin converting enzyme expression in neonatal rat cardiomyocytes. Cardiovasc Res 2003; 57: 139-146.
33. Dahlof B, Pennert K, Hansson L. Reversal of left ventricular hypertrophy in hypertensive patients. A metaanalysis of 109 treatment studies. Am J Hypertens 1992; 5: 95-110.
34. Susic D, Nunez E, Frohlich ED. Reversal of hypertrophy: an active biologic process. Curr Opin Cardiol 1995; 10: 466-472.